World's Best Scientists 2026 revealed!
Award Badge
Immunology
China
2026

D-Index & Metrics

Immunology

D-Index
104
Citations
43107
World Ranking
611
National Ranking
5

Medicine

D-Index
105
Citations
43263
World Ranking
6738
National Ranking
71

Zhigang Tian publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Zhigang Tian sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 517 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Zhigang Tian D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Zhigang Tian sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 104 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in China Leader Award
  • 2025 - Research.com Immunology in China Leader Award
  • 2023 - Research.com Immunology in China Leader Award
  • 2022 - Research.com Immunology in China Leader Award

Overview

Zhigang Tian is affiliated with the University of Science and Technology of China. Their research primarily spans the fields of Immunology and Microbiology, as well as Medicine.

The scientist's work focuses on various subfields including Immunology, Oncology, Molecular Biology, Infectious Diseases, and Epidemiology. This is reflected in their exploration of topics such as:

  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Immune cells in cancer
  • IL-33, ST2, and ILC Pathways
  • Cancer Immunotherapy and Biomarkers

Zhigang Tian has published extensively in several reputed scientific venues. The most frequent publication venues include:

  • Cellular and Molecular Immunology
  • Nature Communications
  • The Journal of Immunology
  • Cell
  • Blood

Among their recent papers are:

  • "Functional exhaustion of antiviral lymphocytes in COVID-19 patients" (2020, Cellular and Molecular Immunology)
  • "Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients" (2020, National Science Review)
  • "A pan-cancer single-cell panorama of human natural killer cells" (2023, Cell)
  • "Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy" (2020, Nature Communications)
  • "Aberrant pathogenic GM-CSF+T cells and inflammatory CD14+CD16+monocytes in severe pulmonary syndrome patients of a new coronavirus" (2020, bioRxiv (Cold Spring Harbor Laboratory))

The scientist frequently collaborates with several co-authors, including:

  • Rui Sun
  • Haiming Wei
  • Xiaohu Zheng
  • Binqing Fu
  • Haoyu Sun

Best Publications

  • Functional exhaustion of antiviral lymphocytes in COVID-19 patients.

    Meijuan Zheng;Yong Gao;Gang Wang;Guobin Song

  • Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

    Yonggang Zhou;Binqing Fu;Xiaohu Zheng;Dongsheng Wang

  • Liver : An Organ with Predominant Innate Immunity

    Bin Gao;Won-Il Jeong;Zhigang Tian

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.

    Qing Zhang;Jiacheng Bi;Xiaodong Zheng;Yongyan Chen

  • Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

    Yiqing Yan;Wei Jiang;Lei Liu;Xiaqiong Wang

  • Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.

    Yiqing Yan;Wei Jiang;Thibaud Spinetti;Thibaud Spinetti;Aubry Tardivel

  • NK cell-based immunotherapy for malignant diseases

    Min Cheng;Yongyan Chen;Weihua Xiao;Rui Sun

  • T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.

    Joel Crespo;Haoyu Sun;Theodore H Welling;Zhigang Tian

  • Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

    Svetlana Radaeva;Rui Sun;Barbara Jaruga;Van T. Nguyen

  • Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells

    Dorothy K Sojka;Beatrice Plougastel-Douglas;Liping Yang;Melissa A Pak-Wittel

  • Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammation

    Jian Wang;Fengqi Li;Haiming Wei;Zhe-Xiong Lian

  • Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

    Hui Peng;Xiaojun Jiang;Yonglin Chen;Dorothy K. Sojka

  • A pan-cancer single-cell panorama of human natural killer cells

    Unknown

  • Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression

    Jingjing Cong;Xianwei Wang;Xiaohu Zheng;Dong Wang

  • RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway

    Xiaqiong Wang;Wei Jiang;Yiqing Yan;Tao Gong

  • Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

    Osamu Asai;Dan L. Longo;Zhi Gang Tian;Ronald L. Hornung

  • Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation.

    Zhigang Tian;Rui Sun;Rui Sun;Rui Sun;Haiming Wei;Haiming Wei;Bin Gao

  • Natural killer cells in liver disease

    Zhigang Tian;Yongyan Chen;Bin Gao

  • HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production

    Xin Yu;Peixiang Lan;Xuben Hou;Qiuju Han

  • Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS

    Feng Hong;Barbara Jaruga;Won Ho Kim;Svetlana Radaeva

  • NK cell-based immunotherapy for cancer.

    Fang Fang;Weihua Xiao;Zhigang Tian

Frequent Co-Authors

Haiming Wei
Haiming Wei University of Science and Technology of China
Rui Sun
Rui Sun University of Science and Technology of China
Rui Sun
Rui Sun Qingdao Municipal Center for Disease Control and Prevention
Bin Gao
Bin Gao National Institutes of Health
William J. Murphy
William J. Murphy Texas A&M University
Zhe-Xiong Lian
Zhe-Xiong Lian University of Science and Technology of China
Dong Wang
Dong Wang Peking University
Xuetao Cao
Xuetao Cao Chinese Academy of Medical Sciences & Peking Union Medical College
Wayne M. Yokoyama
Wayne M. Yokoyama Washington University in St. Louis
Xiang Gao
Xiang Gao Nanjing University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare roles. Many students consider transitioning into nursing specialties that complement their immunology background, such as Nurse Practitioner (NP) fields. For those already working as Family Nurse Practitioners (FNPs), understanding how to shift from fnp to acute care np is vital for career growth.

If you’re seeking to accelerate your nursing career, an accelerated fnp program offers a fast-track pathway to becoming a Family Nurse Practitioner. These programs cater to the demand for skilled practitioners knowledgeable in immunology-related patient care.

For non-nurses interested in entering the field, online RN programs are an excellent starting point. Programs like online rn programs for non nurses in florida provide flexible options for those transitioning from other disciplines. Similarly, exploring absn programs with high acceptance rates can offer accessible routes into nursing by earning a Bachelor of Science in Nursing efficiently.

Combining immunology knowledge with a nursing degree enhances your expertise, making you a valuable asset in clinical, research, or public health settings. These pathways are ideal for students looking to expand their opportunities in healthcare and patient care management.

Best Scientists Citing Zhigang Tian

Trending Scientists

Recently Published Articles